Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis

被引：0
|
作者：
Rodrigo Jorge
Rogério A. Costa
Daniela Calucci
Ingrid U. Scott
机构：
[1] University of São Paulo,Department of Ophthalmology, Ribeirão Preto School of Medicine
[2] Hospital de Olhos de Araraquara,U.D.A.T.—Macular Imaging & Treatment Division
[3] Penn State College of Medicine,Departments of Ophthalmology and Health Evaluation Sciences
[4] Hospital das Clínicas,Departamento de Oftalmologia
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2006年 / 245卷
关键词：
Bevacizumab; Juxtafoveolar telangiectasis; Subretinal neovascularization; VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1045 / 1048
页数：3
相关论文
共 50 条
  • [1] Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis
    Jorge, Rodrigo
    Costa, Rogerio A.
    Calucci, Daniela
    Scott, Ingrid U.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (07) : 1045 - 1048
  • [2] Treatment of idiopathic juxtafoveolar retinal telangiectasis with bevacizurnab (Avastin)
    Schulze, S.
    Mennel, S.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (10) : 787 - 790
  • [3] Familial spastic paraplegia and maculopathy with juxtafoveolar retinal telangiectasis and subretinal neovascularization
    Leys, A
    Gilbert, HD
    Van de Sompel, W
    Verougstraete, C
    Devriendt, K
    Lagae, L
    Gass, JDM
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2000, 20 (02): : 184 - 189
  • [4] Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis
    Berger, AS
    McCuen, BW
    Brown, GC
    Brownlow, RL
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1997, 17 (02): : 94 - 98
  • [5] Regression of retinal and iris neovascularization after intravitreal bevacizumab (avastin) treatment
    Avery, Robert L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (03): : 352 - 354
  • [6] IDIOPATHIC JUXTAFOVEOLAR RETINAL TELANGIECTASIS
    GASS, JD
    OYAKAWA, RT
    ARCHIVES OF OPHTHALMOLOGY, 1982, 100 (05) : 769 - 780
  • [7] Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis
    Potter, MJ
    Szabo, SM
    Sarraf, D
    Michels, R
    Schmidt-Erfurth, U
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2006, 41 (01): : 34 - 37
  • [8] A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
    Karagiannis, Dimitrios
    Georgalas, Ilias
    Ladas, Ioannis
    Eustratios, Parikakis
    Mitropoulos, Panagiotis
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 63 - 65
  • [9] Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy
    Siqueira, Rubens C.
    Costa, Rogerio A.
    Scott, Ingrid U.
    Cintra, Lessia P.
    Jorge, Rodrigo
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (06): : 834 - 835
  • [10] Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia
    Subrata Mandal
    Pradeep Venkatesh
    Zahir Abbas
    Rajpal Vohra
    Satpal Garg
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245
12345